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ABSTRACT
Objective: The aim is to prepare the floating tablet of ciprofloxacin and to improve their bioavailability in the treatment against the Gram-positive 
and Gram-negative microorganisms. Ciprofloxacin HCL is an acidic drug used for respiratory tract infection, diarrhea, skin infection, thyroid fever, 
and urinary tract infection. The ciprofloxacin HCL is primarily absorbed in the stomach and it has low bioavailability. Due to its low availability, it was 
chosen as an appropriate drug for the scheme of the gastroretentive floating drug delivery system.
Method: Ciprofloxacin HCl is an acidic drug which was made by wet granulation process using various polymers, which include hydroxypropyl 
methylcellulose K4M, Eudragit, and Guar gum with a different composition. The gas generating agents such as saleratus and citric acid were used 
for the preparation. The prepared granules were subjected to pre-compression parameters technique and the formulated tablets were subjected to 
post-compression parameters, respectively.
Result: The Fourier-transform infrared analysis reveal that the drug and excipients used for the formulations were compatible with each other. All 
formulated granules having good flow properties and all the post-compression parameter are within the limit in which the F4 formulation shows 
optimum drug release of about 98.7% at 12 h and which has the buoyancy lag time of about 134 s and floating time about 12.5 h. Kinetic treatment 
revealed of the optimized preparation is based on Korsmeyer–Peppas model. The value n=0.861 states the process of non-Fickian diffusion.
Conclusion: Based on above observation found in the work, it was concluded that ciprofloxacin HCl can formulate as a floating drug delivery system 
which helps in increasing the gastric residence time, as a result, it increases the bioavailability and half-life of ciprofloxacin HCl.
Keywords: Floating tablets, Ciprofloxacin hydrochloride, Hydroxypropyl methylcellulose K4M, Buoyancy lag time.
INTRODUCTION
The dynamically controlled system or floating system is low-density 
systems which possess enough buoyant property to float over the 
gastric contents and in the stomach they remain buoyant, and provide 
the prolonged action without changing the gastro emptying rate, which 
leads to an increase in gastroretention time, thereby it control the 
variation in plasma drug concentration [1]. Its importance includes 
lower dosing and fewer side effects and suitable for the drug which 
is easily absorbed in the stomach. The mechanism is that the floating 
drug delivery system has a bulk density lesser than the gastric fluids 
and thus they remain buoyant in the stomach for a long period of time 
without changing the gastro emptying rate. The major advantages 
are enhanced bioavailability, sustained release of drugs [2,3]. The 
hydroxypropyl methylcellulose (HPMC) K4M, Eudragit, and guar gum 
used as the polymers for the preparation of ciprofloxacin floating tablet.
METHODS
Ciprofloxacin was a gift sample obtained from the Micro Labs at Hosur. 
The HPMC K100M and Guar gum were buyed from Loba Chemicals, 
Mumbai. Saleratus, starch, citric acid, and Mg stearate were purchased 
from S.D. Fine Chemicals, Mumbai.
Drug-polymer compatibility studies
Fourier-transform infrared (FTIR) analysis
FTIR study is used to analyze the interactions between the drug, 
excipients, and the polymers. They should be compatible with each 
another to produce a safe, efficacious, and stable product.
The peaks and patterns of the pure drug and the peaks and patterns of the 
combination of drug and polymers were compared with each other [4].
Preparation of ciprofloxacin hydrochloride floating tablet
Ciprofloxacin HCl floating tablet was formulated by wet granulation 
technique, exploitation of numerous polymers such as HPMC K4M, 
Eudragit 100S, guar gum with a combination of sodium bicarbonate, 
and citric acid as the gas generating agent [5]. The various mixture of 
each formulated preparation is given in Table 1.
Ciprofloxacin Hcl is passed through sieve no.20. All the excipients were 
passed through sieve no. 40. Mg stearate is gone through sieve no 60. 
The shifted materials of ciprofloxacin HCl were geometrically mixed 
with the chemical compound and saleratus (sodium bicarbonate), 
and citric acid are blended for 10 min. Then, add starch mucilage 
slowly dropwise manner to create a coherent mass. The granules 
were prepared by passing the coherent mass through sieve no.16. 
The obtained granules are collected and using the hot air oven, it will 
be dried at 40°C±20°C for 2 h. The dried granule was gone through 
sieve no.20. Magnesium stearate is added to the dried granules 
then subjected to pre-formulation studies [6]. The granules of all 




The bulk density is defined as the ratio between a given mass of granules 
or powder and its bulk volume [3]. The exactly weighed amount of 
granules was carefully placed into a 100 ml measuring cylinder, from 
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which the initial volume was measured, and it is calculated by the 
formulae [7].
Bulk density = Weight of granules/bulk volume of granules
Tapped density
Tapped density is defined as the ratio between a given mass of granules 
or powder and the constant or fixed volume of the granules or powder 
after tapping.
Tapped density = Weight of granules/tapped volume of granules
Angle of repose
The angle of repose is the maximum angle possible between the surface 
of the pile of powder and horizontal plane. The fixed funnel method is 
used to determine the angle of repose of the power or granules and to 
study the flow property of the powder or granules. The angle of repose 
(θ) can be determined by the formulae [8].
θ = Tan−1 (h/r)
Where,
θ = Angle of repose,
h = Height of the powder cone,
r = Radius of the powder cone.
Compressibility index (CI) and Hausner ratio
It is a popular method of predicting the flow characteristics of 
granules and powder. The Hausner ratio and the CI are obtained 
by evaluating the tapped density and bulk density of a powder or 
granules.
C.I = Tapped density-bulk density ×100
Tapped density
Hausner ratio = Tapped density⁄bulk density
Characterization of ciprofloxacin HCl floating tablets
General appearance
The general appearance includes the measurement such as a tablets 
shape, size, color, presence or absence of odor and taste, physical flows, 
surface textures, and consistency [9].
Thickness
The thickness of ciprofloxacin HCl floating tablets was measured 
using Vernier calipers. The thickness must be controlled to facilitate 
packaging.
Hardness or crushing strength test
Hardness is defined as the force that required breaking a tablet across 
a diameter [3]. The hardness of the tablet is determined using the 
monsanto hardness tester.
Weight variation test
The under medication or overdose can be possible, if any variation in 
the weight of the tablet. Therefore, tablet of each batch should have 
uniform weight. From each formulation 20 tablets were selected 
randomly and weigh it individually, and the individual tablet weight 
is noted. From the total weight of all tablets, the average weight 
of the tablet was calculated. The individual weights were compared 
with the average weight. Not more than two tablets must differ from 
the average weight. The percentage deviation was determined by the 
following formulae [10].
Percentage deviation






It is studied to ensure the capacity of the tablets to withstand shock, 
while handling, transportation, processing, and packaging. It is usually 
measured using Roche Friabilator [11]. A maximal weight loss should 
not be exceeding 1% of the initial weight of the tablets after 100 
evolutions (25RPM) are considered generally acceptable. The percent 










W1 = Weight of tablets before the test
W2 = Weight of tablets after the test
Estimation of drug content
From each formulation 10 tablets were taken and which is weighed and 
powered the amount of powered equivalent to 100 mg of ciprofloxacin 
HCl was transfer into 0.1N HCl containing volumetric flask of capacity 
100 ml. From the prepared 1 ml of sample was withdrawn and diluted 
to 10 ml using 0.1N HCl and the resulting solution absorbance was 
observed at 277 nm [8].
Floating test
The formulated tablet was kept in 100 ml beaker having 0.1N HCl. 
The time difference between introducing the dosage form and there 
buoyancy on 0.1N HCl and the time at which the drug remain buoyant 
was observed [12].
Buoyancy lag time
The time required for a drug to emerge on the surface of the medium 
is known as floating lag time (FLT) [13]. Total duration of time during 
which the drug remains buoyant is known total floating time (TFT).
In vitro release studies
The in vitro studies were done using USP Type II dissolution test 
apparatus, and it is allowed to rotate at a speed of 50 rpm. The 900 ml 
of 0.1 N HCl was poured in the dissolution medium and dissolution jar 
is maintained at 37±0.5°C. One of the formulated tablet was kept inside 















F1 250 150 - - 50 15 25 10
F2 250 - 150 - 50 15 25 10
F3 250 - - 150 50 15 25 10
F4 250 75 75 - 50 15 25 10
F5 250 - 75 75 50 15 25 10
F6 250 75 - 75 50 15 25 10
F7 250 50 50 50 50 15 25 10
HPMC: hydroxypropyl methylcellulose
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the dissolution medium, after 1-h time interval 10 ml of sample was 
withdrawn, and the absorbance is noted. The sample is collected up 
to 12 h and replaced with the same volume of medium. After suitable 
dilution, the samples were analyzed at 277 nm using UV double beam 
spectrophotometer [6,14].
Release kinetics
The data observed from the in vitro studies were fitted to different 
kinetic equations which includes zero-order, first-order, Korsmeyer–
Peppas model, and Higuchi model [15].
Zero-order equation: (Q = Q0–k0t)
First-order equation: (In Q = Qo–K1t)
Higuchi equation: (Q = K2 t1/2)
Korsmeyer–peppers: (Q/Q0 = K tn)
RESULTS AND DISCUSSION
Preformulation studies of granules of ciprofloxacin HCl floating 
tablets
The granules of ciprofloxacin HCl floating tablets were formulated 
by wet granulation method. The prepared granules are introduced to 
preformulation studies, and the results are presented in Table 2.
The bulk density of the granules ranges from 0.32 to 0.393. The tapped 
density of the granules ranged from 0.417 to 0.49. The angle of repose 
ranges from 22°71’ to 26°15’. The CI and Hausner’s ratio of the prepared 
granules ranged from 9.86 to 15.39 and 1.12 to 1.18, respectively. The 
results showed that the granules of all formulations showed excellent 
flow properties.
Characterization of ciprofloxacin HCl floating tablets
General appearance
The prepared tablets were estimated for organoleptic characters. The 
tablets are circular in shape, yellowish in color, with no characteristic 
odor. All tablets showed elegance in appearance.
The compressed tablet was estimated by various physical parameters. 
The results are presented in Table 3. The rigidity of the tablets ranges 
from 4.84 to 5.56 and percentage friability of all formulation within the 
range of 0.23–0.40%. The thickness ranged from 4.1 mm to 4.4 mm. 
Here, all the parameters are within the acceptable range. Hence, all the 
formulated tablets were falls within limits.
Weight variation test
All the formulated tablets undergo the weight variation test, and 
their percentage weight variations were within the pharmacopeial 
range. As a result, the weight of all tablets shows the low standard 
deviation values and found to be uniform, and the results are shown 
in Table 4.
Estimation of drug content
Drug content estimation shows that all the batches of formulated 
tablets are within the prescribed limits. It reveals that the drug and the 
excipients were mixed properly and the results are given in Table 4.
Buoyancy lag time
It is the time required during which the drug remains buoyant on 0.1N 
HCl was measured, and the results are given in Table 5. The buoyancy 
lag time value was seen in the range of 134–166 s.
TFT
It is defined as the total duration of time required during which the drug 
remains buoyant is measured, and the values were ranges between 356 
and 485 min and the results are given in Table 5.
IR spectral analysis
The IR spectral studies of pure ciprofloxacin HCL, HPMC K4M, Eudragit, 
and Guar gum were done to study the drug-polymer interactions. It 
states that the IR spectrum of pure ciprofloxacin HCL and polymers 
have similar fundamental peaks and patterns. It reveals that there is 
no significant interaction within the drug and polymers. The results are 
shown in Figs. 1-8.
In vitro dissolution studies
An in vitro study was done to evaluate the dissolution character of 
ciprofloxacin HCL from floating tablets using three polymers with 
different ratios. The in vitro evaluation results are presented in Table 6. 
The graphical representation of the data is shown in Fig. 9.
The percentage drug release of all prepared formulations after 12 h 
using HPMC K4M, Eudragit 100S, and guar gum was found to be 
88.12% (F1), 90.68% (F2), and 73.45% (F3), respectively. Moreover, 
Table 2: Preformulation studies of granules of ciprofloxacin HCl floating tablets








CI (%) Hausner’s 
ratio
1 F1 22º71´ 0.32 0.49 11.22 1.16
2 F2 22º9´ 0.386 0.435 11.34 1.12
3 F3 24º5´ 0.393 0.436 9.86 1.12
4 F4 24º01′ 0.375 0.429 12.59 1.14
5 F5 25º1´ 0.371 0.417 11.16 1.13
6 F6 26º1´ 0.380 0.448 10.714 1.10
7 F7 24º9´ 0.391 0.455 15.39 1.18
CI: Compressibility index
Table 3: Evaluation of ciprofloxacin HCl floating tablets
S. No. Formulation code Hardness (kg/cm) Friability (%) Thickness (mm) Diameter (mm)
1 F1 4.85 0.631 4.17 10.19
2 F2 4.8 0.413 5.14 10.8
3 F3 5.1 0.462 5.16 11.0
4 F4 4.75 0.381 4.4 10.7
5 F5 4.5 0.54 4.16 10.9
6 F6 5.0 0.761 4.5 11.0
7 F7 4.8 0.62 4.2 10.8
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the percentage drug release of a combination of HPMC K4M with 
Eudragit 100S is 98.87% (F4), Eudragit 100S with guar gum is 85.67% 
(F5), HPMC K4M with guar gum is 79.93% (F6), and HPMC K4M with 
Eudragit 100S and guar gum is 95.45% (F7).
From the in vitro evaluation study, it was observed that maximum 
drug release found in formulation F4 is 98.87%. It shows that F4 
formulation exhibits optimized drug release when compared with 
other formulation.
Kinetic analysis of dissolution data
The absorbed data were treated in case of zero-order, first-order, 
Korsmeyer– Peppas model, and Higuchi’s model to study the 
mechanism of drug release of prepared formulations. The release 
rate kinetic data for all the formulations were given in Table 7, the 
graphical representation of the data is shown in Figs. 10-13. The 
formulation showed high linearity when plotted in zero-order kinetics 
with regression coefficient values (R2) between 0.993 and 0.998.
Diffusion is the process in which the drug moved from the dosage 
matrix into the in vitro study fluid based on the concentrations. This is 
governed by Higuchi’s equations, as the plot reveals the high linearity 
with regression coefficient values (R2) between 0.878 and 0.938.
Fig. 1: Fourier-transform infrared spectrum of ciprofloxacin HCl
Fig. 2: Fourier-transform infrared spectrum of hydroxypropyl 
methylcellulose K4M
Fig. 3: Fourier-transform infrared spectrum of Eudragit 100S
Fig. 5: Fourier-transform infrared spectrum of ciprofloxacin HCl 
and hydroxypropyl methylcellulose K4M
Fig. 6: Fourier-transform infrared spectrum of ciprofloxacin HCl 
and Eudragit 100S
Fig. 4: Fourier-transform infrared spectrum of Guar gum
Table 4: Weigh variation and estimation of drug content of 
floating tablets





1 F1 498±2.5 98.12
2 F2 496±3.2 97.23
3 F3 497±2.7 98.63
4 F4 499±1.13 99.54
5 F5 498±3.5 97.83
6 F6 495±4.3 97.38
7 F7 497±4.2 99.17
Table 5: FLT and floating time of different formulations
S.No Formulation code FLT (Sec) Floating time (h)
1 F1 150 10.0
2 F2 144 10.5
3 F3 151 8.0
4 F4 134 12.5
5 F5 154 9.0
6 F6 166 9.5
7 F7 140 11.0
FLT: Floating lag time
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Using Korsmeyer–Peppas model, if n=0.45, it is Fickian diffusion, if 
n=0.45–0.89 it is non-Fickian transport. Here, all the formulations 
Table 6: Comparative in vitro dissolution study of ciprofloxacin HCl floating tablets (F1-F7)
Time (h) Cumulative % drug release
F1 F2 F3 F4 F5 F6 F7
1 11.22 9.43 8.24 12.18 9.91 10.51 10.98
2 14.3 16.13 10.38 20.9 12.83 12.22 19.06
3 19.8 21.51 13.68 27.13 16.86 15.27 24.81
4 27.01 29.94 18.7 36.78 24.2 21.38 31.04
5 33.73 35.93 25.66 44 31.16 29.82 39.23
6 39.84 41.8 30.18 52.43 37.4 36.17 45.58
7 47.3 50.23 36.3 60.74 41.8 40.94 51.08
8 53.04 58.17 42.04 69.05 50.23 48.15 61.47
9 63.92 68.68 51.45 77.24 58.91 54.02 70.52
10 71.98 75.28 57.81 85.43 68.07 62.57 81.64
11 79.81 82.13 69.91 91.91 76.14 72.47 87.02
12 88.12 90.68 73.45 98.87 85.67 79.93 95.45
Fig. 7: Fourier-transform infrared spectrum of ciprofloxacin HCl 
and Guar gum
Fig. 8: Fourier-transform infrared spectrum of ciprofloxacin HCl, 
hydroxypropyl methylcellulose K4M, Eudragit 100S, Guar gum, 
sodium bicarbonate, and citric acid
Fig. 9: Comparative in vitro dissolution study of ciprofloxacin HCl 
floating tablets (F1-F7)
Fig. 10: Zero-order drug release kinetics of F4
Fig. 11: First-order drug release kinetics of F4
Fig. 12: Higuchi model of drug release kinetics for F4
showed “n” values between 0.806 and 0.929. Hence, all the formulations 
follow non-Fickian diffusion transport mechanism.
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CONCLUSION
Hydrodynamically balanced tablets of ciprofloxacin HCl can be 
formulated with an approach to improve drug bioavailability and 
to increase gastric residence. The developed floating tablets of 
ciprofloxacin HCl were formulated using HPMC K4M, Eudragit100S, 
and guar gum as polymers and sodium bicarbonate combination 
with citric acid as the gas generating agent which is prepared by wet 
granulation technique and evaluated. The result states that all the 
parameters are within the range. When comparing all formulation, 
F4 showed optimized drug release of 98.87% at the end of 12 h. 
The optimized F4 formulation showed buoyancy lag time of 134 sec 
and floating time of 12.5 h, respectively. Data obtained from the 
kinetic treatment show F4 formulations follow Korsmeyer–Peppas 
model. The n=0.861 indicates the non-Fickian diffusion. From the 
above study, it was concluded that ciprofloxacin HCl can formulate 
as a floating drug delivery system with more bioavailable, safe, 
and economical drug and which helps to increase gastric residence 
time thereby it increases the bioavailability and half-life of 
ciprofloxacin HCl.
Table 7: Kinetic analysis of dissolution data
S. No Formulation code Regression coefficient (R2) Korsmeyer’ plot
Zero-order plot First-order plot Higuchi’s plot R2 Slope (n)
1 F1 0.993 0.886 0.896 0.970 0.887
2 F2 0.997 0.889 0.910 0.993 0.929
3 F3 0.988 0.880 0.878 0.997 0.868
4 F4 0.998 0.763 0.938 0.996 0.861
5 F5 0.988 0.880 0.878 0.998 0.806
6 F6 0.988 0.880 0.878 0.998 0.825
7 F7 0.995 0.832 0.912 0.990 0.877
Fig. 13: Peppas model of drug release kinetics forF4
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